MED

DEVICE3 trials

Sponsors

University of Manchester, University of Illinois at Chicago, Stanford University

Conditions

Colorectal CancerDiet HabitPrediabetes / Type 2 DiabetesVision, Low

Phase 4

Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention

Not yet recruitingNCT06682351

Stanford UniversityPrediabetes / Type 2 Diabetes

Start: 2024-11-30End: 2027-12-31Target: 200Updated: 2024-11-12

Unknown Phase

Mobile Electronic Devices for Visual Impairment

TerminatedNCT03560765

University of ManchesterVision, Low

Start: 2018-08-01End: 2020-08-01Updated: 2021-11-19

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer

RecruitingNCT04753359

University of Illinois at ChicagoColorectal Cancer, Diet Habit

Start: 2022-02-01End: 2025-03-31Target: 232Updated: 2024-08-21

Related Papers

Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity.

2023-02-1514 citations